Guillain–Barré Syndrome (GBS) is the most frequent cause of acute flaccid paralysis worldwide and constitute one of serious emergencies in neurology. In Ethiopia there is high prevalence of infectious disease influencing the prevalence as well as the subsequent outcome of GBS where there is significant constrain in the availability of critical care, rehabilitation and social service. So, the objective of this study is assessing predictors and outcomes of Guillain-Barré Syndrome. Retrospective cross sectional study was used and all patients who fulfill the inclusion criteria’s for GBS in the 7 years period were included. The organized data was interpreted using descriptive methods in the form of tables, charts, and graphs in the SPSS version 20 and Excel software. Binary logistic regression analysis was used to assess the association between exposure variables and outcome of GBS. And univariate analysis performed to screen out potentially significant independent variables to be included in the multivariable binary logistic regression. The most common presenting symptoms were muscle weakness (91), respiratory muscle involvement (32) and Cranial Nerve involvement (27). HIV (40.64%) and DM (31.25%) were important comorbid illness. Cranial nerve palsies, respiratory compromise, disability score, need of mechanical ventilation, HIV and DM were significantly associated with worse outcome. Common GBS variants identified were AMAN (36%) and AIDP (30%), AMAN type were associated with unfortunate outcome. GBS-specific therapy was administered in 43.96% patients and having appropriate treatment had lower incidence of poor outcome. Generally, this study showed 60% of patients had good outcome (GDS ≤ 2) and 40% of bad outcome (GDS > 2). Digitization of medical recording evaluation report using a software based template would help to improve the completeness of each patient report and awareness of predictors of GBS outcome and being perceptive for alarming features will help allocate resource in keen manner in our resource restricted setting. Having GBS specific treatments available in affordable and accessible manner will inflict significant light in the prognosis of GBS patients. It would be better to conduct further studies on Concordance between molecular tests, anti-body, sequential electro-diagnostic tests and availability of physiotherapy to have better model that predict outcome of GBS.
Published in | American Journal of Nursing and Health Sciences (Volume 3, Issue 3) |
DOI | 10.11648/j.ajnhs.20220303.15 |
Page(s) | 73-83 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2022. Published by Science Publishing Group |
GBS Disability Score, Guillain–Barré Syndrome, Outcome, Predictors
[1] | M. D., P.h.D Nobuhiro Yuki and Hans-Peter Hartung, M. D., "Guillain–Barré Syndrome," N Engl J Med, vol. 366, pp. 2294-304, June 14, 2012. |
[2] | Hughes RAC, Swan AV, Raphaël JC,, "Immunotherapy for Guillain-Barré," vol. 130, pp. 2245-57, Brain 2007. |
[3] | Sejvar JJ, Baughman AL, Wise M,, "Population incidence of," Neuroepidemiology, vol. 36, pp. 123-33, 2011. |
[4] | Van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn, "Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and," Nat Rev Neurol, vol. 10, pp. 469-82, 2014. |
[5] | Walgaard C, Lingsma HF, Ruts L, van Doorn PA, Steyerberg EW, Jacobs, "Early recognition of poor prognosis in Guillain-Barre syndrome.," Neurology, vol. 76, pp. 968-75, 2011. |
[6] | James J. Sejvar Andrew L. Baughman Matthew Wise Oliver W. Morgan, "Population Incidence of Guillain-Barré," Neuroepidemiology, vol. 36, p. 123–133. |
[7] | Willison HJ, Jacobs BC, van Doorn PA, "Guillain-Barre syndrome," Lancet, vol. 388, pp. 717-27, 2016. |
[8] | World Health Organization, "Situation Report: Zika virus, Microcephaly, Guillain-Barré syndrome," vol. 2, June 2016. |
[9] | Hughes RA, Cornblath DR, "Guillain-Barré syndrome," Lancet, vol. 366, p. 1653–66, 2005. |
[10] | Nowe T, Huttemann K, Engelhorn T, Schellinger PD, Kohrmann M, "Paralytic ileus as a presenting symptom of Guillain-Barré," J Neurol, vol. 255, p. 756–57, 2008. |
[11] | Asbury AK, Cornblath DR, "Assessment of current diagnostic criteria," Ann Neurol, vol. 27, pp. 21-24, 1990. |
[12] | van der Meché FG, van Doorn PA, Meulstee J, Jennekens FG, "Diagnostic and classification criteria for the Guillain-Barré," Eur Neurol, vol. 45, pp. 133-39, 2001. |
[13] | H. Z. S. B. K. B. Alshekhlee A, "Guillain-Barré," Neurology, vol. 70, p. 1608, 2008. |
[14] | Pieter A van Doorn, Liselotte Ruts, Bart C Jacobs, "Clinical features, pathogenesis, and treatment of," Lancet Neurol, vol. 7, p. 939–50, 2008. |
[15] | Joshua Saisha, Margaret M. Mweshi, Martha Banda-Chalwe, Loveness A. Nkhata, Elliot Kafumukache, Micah Simpamba, Namalambo, "The Prevalence of Guillian-Barre Syndrome and the Rate of Physiotherapy Referral at the University Teaching Hospital,," International Journal of Neurologic Physical Therapy., vol. 2, pp. 1-4, 2015. |
[16] | Sejvar JJ, Kohl KS, Gidudu J, et al, "Guillain-Barré syndrome and Fisher syndrome," Vaccine, vol. 29, pp. 599-612, 2011. |
[17] | Nishimoto Y, Odaka M, Hirata K, Yuki, "Usefulness of anti-GQ1b IgG antibody," J Neuroimmunol, vol. 148, pp. 200-5, 2004. |
[18] | van Koningsveld R, Steyerberg EW, Hughes RA, Swan AV, van Doorn PA, Jacobs BC, "A clinical prognostic scoring system for Guillain-Barre´ syndrome," Lancet Neurol, vol. 6, p. 589–594, 2007. |
[19] | Jacobs BC, Van Den Berg B, Verboon C, Chavada G, Cornblath DR, Gorson KC, et al, "International Guillain-Barre´ Syndrome Outcome Study," J Peripher Nerv Syst, vol. 22, p. 68–76, 2017. |
[20] | R Korinthenberg, J Schulte Mnting, "Natural history and treatment effects in," Archives of Disease, vol. 74, pp. 281-287, 1996. |
[21] | Tigist Bacha, MD, MPH, Wondemagegne Gezahegn, MD, Ashenafi Amare, MD, "THE CLINICAL PRESENTATION, EPIDEMIOLOGY, AND SHORT-TERM OUTCOME," Ethiop Med J, vol. 56, pp. 142-146, 2018. |
[22] | N. K. Alzaidi MA, "Guillain-Barre Syndrome pattern of muscle weakness," Neurosci Riyadh Riyadh Saudi Arab, vol. 7, pp. 176-8, 2002. |
[23] | V. C. v. d. B. B. H. T. C. D. W. H. e. a. Doets AY, "Regional variation of Guillain-Barre' syndrome," Brain J Neurol, vol. 286, p. 141, 2018. |
[24] | Ishaque T, Islam MB, Ara G, Endtz HP, Mohammad QD, Jacobs BC,, "High mortality from Guillain-in Bangladesh," J Peripher Nerv Syst., vol. 22, p. 121–6, 2017. |
[25] | M. G. S. H. a. d. V. C. McGrogan A, "The epidemiology of Guillain-Barré syndrome worldwide." Vols. Neuroepidemiology 32: 150-163., 2009. |
[26] | A. E. E. C. Enwere OO, "Human immunodeficiency virus infection presenting as a fatal case of," Int J Med and Biomed Res, Vols. vol 4 (2): 82-85, 2015. |
[27] | A. B. Khan F, "Rehabilitation interventions in patients with acute inflammatory polyneuropathy: A systematic review.," Eur J Phys Rehab Med, vol. 48, pp. 507-22, 2012. |
[28] | Z. DW, "Autonomic involvement in Guillain-Barré syndrome: a review.," Muscle Nerve, vol. 17, pp. 1145-55, 1994. |
[29] | A. F. M. Mukerji S, "Cardiovascular complications of the Guillain-Barré syndrome.," Am J Card, vol. 104, pp. 1452-55, 2009. |
[30] | N.-H. K. Soo-Hyun Park, "Early Prediction Factors of Poor Outcome in Guillain-Barre Syndrome," Soonchunhyang Med Sci >, vol. 22 (2), 2016. |
[31] | T. U.-K. Ryuji Sakakibara, "Prevalence and Mechanism of Bladder Dysfunction in Guillain-Barre Syndrome," Neurourology and Urodynamics, vol. 28 (5), pp: 432-7, June 2009. |
[32] | M. A. K. Maha Shangaba, "Clinical Course and Predictors of Poor Functional Outcome in Guillain-Barré Syndrome. A Retrospective Study," Dubai Med J, vol. 3, pp. 93-98, 2020. |
[33] | F. D. R. T. W. E. Lawn ND, "Anticipating mechanical ventilation in Guillain-Barré syndrome," Arch Neurol, vol. 58, pp. 893-8, 2001. |
[34] | Melaku Z, Zenebe G, Bekele A., "Guillain-Barré syndrome in Ethiopian patients," Ethiop Med J, vol. 43, pp: 21-6, 2005 Jan. |
[35] | Mitsui Y, Kusunoki S, Arimura K, Kaji R, Kanda T, Kuwabara S, et al., "A multicentre prospective study of GuillainBarre Syndrome in Japan," J NeurolNeurosurg, vol. 86, pp. 110-4, 2015. |
[36] | P. K. Gupta, “A Comparison of Clinical Profile and Short-Term Outcome of Demyelinating and Axonal Subtypes of Guillain-Barré Syndrome in Children”., EC Paediatrics, vol. 8, pp. 1064-73, 2019. |
[37] | Guillain G, Barré JA and Strohl A., "On radiculo-neuritis syndrome with hyperalbuminosis of cerebrospinal fluid without cellular reaction. Remarks on the clinical and graphic characteristics of tendon reflexe," Bull Soc Med Hop Paris, vol. 40, pp. 1462-1470. |
[38] | Mohammed H. Alanazy, Sawsan S. Bakry, Afnan Alqahtani, Norah S. AlAkeel, Naael Alazwar, fag M. Osman, Rania A. Mustafa, Talal M. Al Harb, Sameeh O. Abdulmana, Aimee C. Amper, Yousef Aldughaythir, Abdulrahman S. Ali, Seraj Makkawi, Alaa, "Clinical features and outcome of Guillain-Barre aaaaaaSyndrome in Saudi Arabia; a multicenter, retrospective study," BMC Neurol, vol. 21, p. 275, 2021. |
[39] | H. AF, "Guillian- Barr syndrome," Lancet, vol. 41, p. 635, 1998. |
APA Style
Wubakal Teshome, Tesfaye Dagne, Tsegaye Getachew. (2022). Assessing the Predictors and Outcomes of Guillain-Barré Syndrome at St. Paul’s and Zewditu Hospitals in Addis Ababa, Ethiopia. American Journal of Nursing and Health Sciences, 3(3), 73-83. https://doi.org/10.11648/j.ajnhs.20220303.15
ACS Style
Wubakal Teshome; Tesfaye Dagne; Tsegaye Getachew. Assessing the Predictors and Outcomes of Guillain-Barré Syndrome at St. Paul’s and Zewditu Hospitals in Addis Ababa, Ethiopia. Am. J. Nurs. Health Sci. 2022, 3(3), 73-83. doi: 10.11648/j.ajnhs.20220303.15
@article{10.11648/j.ajnhs.20220303.15, author = {Wubakal Teshome and Tesfaye Dagne and Tsegaye Getachew}, title = {Assessing the Predictors and Outcomes of Guillain-Barré Syndrome at St. Paul’s and Zewditu Hospitals in Addis Ababa, Ethiopia}, journal = {American Journal of Nursing and Health Sciences}, volume = {3}, number = {3}, pages = {73-83}, doi = {10.11648/j.ajnhs.20220303.15}, url = {https://doi.org/10.11648/j.ajnhs.20220303.15}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajnhs.20220303.15}, abstract = {Guillain–Barré Syndrome (GBS) is the most frequent cause of acute flaccid paralysis worldwide and constitute one of serious emergencies in neurology. In Ethiopia there is high prevalence of infectious disease influencing the prevalence as well as the subsequent outcome of GBS where there is significant constrain in the availability of critical care, rehabilitation and social service. So, the objective of this study is assessing predictors and outcomes of Guillain-Barré Syndrome. Retrospective cross sectional study was used and all patients who fulfill the inclusion criteria’s for GBS in the 7 years period were included. The organized data was interpreted using descriptive methods in the form of tables, charts, and graphs in the SPSS version 20 and Excel software. Binary logistic regression analysis was used to assess the association between exposure variables and outcome of GBS. And univariate analysis performed to screen out potentially significant independent variables to be included in the multivariable binary logistic regression. The most common presenting symptoms were muscle weakness (91), respiratory muscle involvement (32) and Cranial Nerve involvement (27). HIV (40.64%) and DM (31.25%) were important comorbid illness. Cranial nerve palsies, respiratory compromise, disability score, need of mechanical ventilation, HIV and DM were significantly associated with worse outcome. Common GBS variants identified were AMAN (36%) and AIDP (30%), AMAN type were associated with unfortunate outcome. GBS-specific therapy was administered in 43.96% patients and having appropriate treatment had lower incidence of poor outcome. Generally, this study showed 60% of patients had good outcome (GDS ≤ 2) and 40% of bad outcome (GDS > 2). Digitization of medical recording evaluation report using a software based template would help to improve the completeness of each patient report and awareness of predictors of GBS outcome and being perceptive for alarming features will help allocate resource in keen manner in our resource restricted setting. Having GBS specific treatments available in affordable and accessible manner will inflict significant light in the prognosis of GBS patients. It would be better to conduct further studies on Concordance between molecular tests, anti-body, sequential electro-diagnostic tests and availability of physiotherapy to have better model that predict outcome of GBS.}, year = {2022} }
TY - JOUR T1 - Assessing the Predictors and Outcomes of Guillain-Barré Syndrome at St. Paul’s and Zewditu Hospitals in Addis Ababa, Ethiopia AU - Wubakal Teshome AU - Tesfaye Dagne AU - Tsegaye Getachew Y1 - 2022/09/29 PY - 2022 N1 - https://doi.org/10.11648/j.ajnhs.20220303.15 DO - 10.11648/j.ajnhs.20220303.15 T2 - American Journal of Nursing and Health Sciences JF - American Journal of Nursing and Health Sciences JO - American Journal of Nursing and Health Sciences SP - 73 EP - 83 PB - Science Publishing Group SN - 2994-7227 UR - https://doi.org/10.11648/j.ajnhs.20220303.15 AB - Guillain–Barré Syndrome (GBS) is the most frequent cause of acute flaccid paralysis worldwide and constitute one of serious emergencies in neurology. In Ethiopia there is high prevalence of infectious disease influencing the prevalence as well as the subsequent outcome of GBS where there is significant constrain in the availability of critical care, rehabilitation and social service. So, the objective of this study is assessing predictors and outcomes of Guillain-Barré Syndrome. Retrospective cross sectional study was used and all patients who fulfill the inclusion criteria’s for GBS in the 7 years period were included. The organized data was interpreted using descriptive methods in the form of tables, charts, and graphs in the SPSS version 20 and Excel software. Binary logistic regression analysis was used to assess the association between exposure variables and outcome of GBS. And univariate analysis performed to screen out potentially significant independent variables to be included in the multivariable binary logistic regression. The most common presenting symptoms were muscle weakness (91), respiratory muscle involvement (32) and Cranial Nerve involvement (27). HIV (40.64%) and DM (31.25%) were important comorbid illness. Cranial nerve palsies, respiratory compromise, disability score, need of mechanical ventilation, HIV and DM were significantly associated with worse outcome. Common GBS variants identified were AMAN (36%) and AIDP (30%), AMAN type were associated with unfortunate outcome. GBS-specific therapy was administered in 43.96% patients and having appropriate treatment had lower incidence of poor outcome. Generally, this study showed 60% of patients had good outcome (GDS ≤ 2) and 40% of bad outcome (GDS > 2). Digitization of medical recording evaluation report using a software based template would help to improve the completeness of each patient report and awareness of predictors of GBS outcome and being perceptive for alarming features will help allocate resource in keen manner in our resource restricted setting. Having GBS specific treatments available in affordable and accessible manner will inflict significant light in the prognosis of GBS patients. It would be better to conduct further studies on Concordance between molecular tests, anti-body, sequential electro-diagnostic tests and availability of physiotherapy to have better model that predict outcome of GBS. VL - 3 IS - 3 ER -